Pain, Drugs, and Ethics

Zacharoff, Kevin L., Migdal, Phyllis

  • 出版商: Springer
  • 出版日期: 2024-10-28
  • 售價: $4,300
  • 貴賓價: 9.5$4,085
  • 語言: 英文
  • 頁數: 209
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 3031630173
  • ISBN-13: 9783031630170
  • 尚未上市,無法訂購

商品描述

Pain remains one of the most common reasons that people seek medical attention in the United States today. One of the ways health care providers responded to pain being designated the "5th vital sign" was with their prescription pads. In order to respond to subjective pain-ratings, opioid analgesics began to be prescribed more liberally than in the past, presumably with the intention of responding to information about pain-related complaints now captured in routine assessments. This was in concert with several other circumstances, including the appearance and promulgation of "pill mills", questionable marketing practices by opioid manufacturers, and increasing rates of abuse, misuse, and addiction related to opioid analgesics. All this taking place in an environment of tremendous educational deficits related to pain, its assessment and treatment, and risks of aberrant drug-related behaviors.

There is now a challenge to balancing the safe, compassionate, and effective treatment of chronic pain against serious negative outcomes associated with the increased abuse and misuse of these medications. With overdose death rates increasing, tensions running high, a multitude of political and regulatory involvement, and "knee-jerk" reactiveness, it seems as if the only thing being forgotten are the needs of chronic pain patients and the core ethical principles intended to help clinicians maintain the highest ethical standards of care.

This book delves into this background and offers the context of professionalism and ethics taught to most healthcare professionals today, and describes how these principles can help to maximize safety, efficacy, and compassionate pain care, regardless of the direction the "opioid pendulum" is swinging. A framework is provided for clinicians to rely on best practices in managing acute, subacute, and chronic pain. The goal is to help clinicians provide patients with pain the most reliable, contextual, and ethical pain care possible.

Pain, Drugs, and Ethics is written for the multiple disciplines involved in managing patients with pain today.

商品描述(中文翻譯)

疼痛仍然是當今美國人尋求醫療協助的最常見原因之一。醫療提供者對於疼痛被指定為「第五個生命徵象」的回應之一,就是使用處方簽。為了回應主觀的疼痛評估,鴉片類止痛藥的處方開始比過去更加寬鬆,這大概是出於回應現在在常規評估中捕捉到的與疼痛相關的投訴資訊的意圖。這與幾個其他情況相互呼應,包括「藥丸工廠」的出現和推廣、鴉片製造商的可疑行銷做法,以及與鴉片類止痛藥相關的濫用、誤用和成癮率的上升。所有這一切都發生在與疼痛、其評估和治療以及異常藥物行為風險相關的巨大教育缺口的環境中。

現在面臨的挑戰是如何在安全、富有同情心和有效的慢性疼痛治療與這些藥物濫用和誤用所帶來的嚴重負面後果之間取得平衡。隨著過量死亡率的上升、緊張局勢的加劇、眾多的政治和監管介入,以及「膝反射式」的反應,似乎唯一被遺忘的就是慢性疼痛患者的需求以及旨在幫助臨床醫生維持最高倫理標準的核心倫理原則。

本書深入探討這一背景,提供當今大多數醫療專業人員所學的專業性和倫理的背景,並描述這些原則如何幫助最大化安全性、有效性和富有同情心的疼痛護理,無論「鴉片擺錘」的擺動方向如何。為臨床醫生提供了一個框架,以依賴最佳實踐來管理急性、亞急性和慢性疼痛。目標是幫助臨床醫生為疼痛患者提供最可靠、最具情境性和最具倫理的疼痛護理。

《疼痛、藥物與倫理》是為當今涉及管理疼痛患者的多個學科而寫的。

作者簡介

Kevin L. Zacharoff, MD, FACIP, FACPE, FAAP

Clinical Assistant Professor

Course Director Pain and Addiction

Distinguished Visiting Scholar In Medical Humanities, Compassionate Care, and Bioethics

Department of Family, Population, and Preventive Medicine, Renaissance School of Medicine at Stony Brook University

External Ethics Consultant Stony Brook University Hospital

Consultant to the Anesthetic and Analgesic Drug Products Advisory Committee to the U.S. Food and Drug Administration

Phyllis Migdal

Clinical Assistant Professor

Department of Family, Population and Preventive Medicine, Renaissance School of Medicine

Institutional Ethics Committee member Stony Brook University Hospital

作者簡介(中文翻譯)

Kevin L. Zacharoff, MD, FACIP, FACPE, FAAP
臨床助理教授
疼痛與成癮課程主任
醫學人文、同情護理與生物倫理學傑出訪問學者
紐約州立大學石溪分校文藝復興醫學院家庭、人口與預防醫學系
紐約州立大學石溪分校醫院外部倫理顧問
美國食品藥品監督管理局麻醉與鎮痛藥品諮詢委員會顧問

Phyllis Migdal
臨床助理教授
紐約州立大學石溪分校文藝復興醫學院家庭、人口與預防醫學系
紐約州立大學石溪分校醫院機構倫理委員會成員